to Assess the Efficacy and Safety of the Probiotic E. Coli Strain M17 on Patients With GERD

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 31, 2006

Study Completion Date

May 31, 2007

Conditions
GERD
Interventions
DRUG

ProBactrix

Trial Locations (1)

Unknown

Shaarei Zedek Medical Center, Jerusalem

Sponsors
All Listed Sponsors
lead

BioBalance Corporation

INDUSTRY